- 3D-printed mini-organs may provide safe testing of COVID-19 therapies
- Novoheart Named 2020 Venture 50 Company Ranked Among Year’s Top Performing Stocks in Life Sciences
- Novoheart Contracts with Global Pharma to Develop Novel Microplate for High Throughput Drug Screening Using Engineered Human Heart Tissue Strips
- Continued Success of Novoheart to Receive R&D Grants: Innovation Technology Fund for Developing Smart Cardiac Screening Technologies
- Heart-In-A-Jar Platform Humanizing Preclinical Research
No comments to show.